New nasal spray aims to stop asthma Flare-Ups triggered by common cold
NCT ID NCT07488897
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a nasal spray called RIG-101 in healthy people and those with asthma. First, it checks safety and tolerability. Then, asthma participants receive the spray daily and are exposed to a cold virus to see if it prevents asthma worsening. The trial is recruiting 82 adults aged 18-65.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RIG-101 (nasal spray)
What this could lead to
If successful, this could point toward a new treatment to prevent asthma flare-ups triggered by common cold viruses.
What could go wrong
This is an early combined Phase 1-2 trial with only 82 participants, so safety and efficacy are not yet proven. The viral challenge part is artificial and may not reflect real-world conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medicines Evaluation Unit
RECRUITINGManchester, M23 9QZ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virtus Respiratory Research Ltd
NOT_YET_RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••